In silico and in vitro investigations of antihelmintic activities of selected approved drugs
<p>Objective: We investigated the binding affinities of some approved drugs to Ascaris suum Mitochondrial Rhodoquinol Fumarate Reductase (MRFR), an essential enzyme for ascaris survival, and the possibility of repurposing these drugs as antihelmintic agents using in silico molecular docking an...
Wedi'i Gadw mewn:
Prif Awduron: | Christopher Arinze Agube (Awdur), Daniel Lotanna Ajaghaku (Awdur), Ikemefuna Chijioke Uzochukwu (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Archives of Community Medicine and Public Health - Peertechz Publications,
2020-11-27.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity
gan: Luiza S. E. P. Will Castro, et al.
Cyhoeddwyd: (2021) -
In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals
gan: Deniz Al Tawalbeh, et al.
Cyhoeddwyd: (2022) -
Inhibition of oxidative stress and gastric emptying as additional mechanisms of antidiabetic activity of Newbouldia laevis
gan: Ikechukwu Sonne Mbagwu, et al.
Cyhoeddwyd: (2021) -
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
gan: Tiziana Ginex, et al.
Cyhoeddwyd: (2021) -
Dostarlimab: From preclinical investigation to drug approval and future directions
gan: Carlo Maria Cicala, et al.
Cyhoeddwyd: (2023)